|
IL6ST expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.88380000382327E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.75590000001714E-08 |
| Normal-vs-Stage2 |
5.8790999999947E-05 |
| Normal-vs-Stage3 |
6.08970000000042E-05 |
| Normal-vs-Stage4 |
8.340900E-03 |
| Stage1-vs-Stage2 |
9.036400E-01 |
| Stage1-vs-Stage3 |
4.462800E-01 |
| Stage1-vs-Stage4 |
7.514000E-01 |
| Stage2-vs-Stage3 |
5.866800E-01 |
| Stage2-vs-Stage4 |
8.427600E-01 |
| Stage3-vs-Stage4 |
9.089200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93969999950916E-07 |
| Normal-vs-AfricanAmerican |
1.39760000017475E-07 |
| Normal-vs-Asian |
1.821780E-03 |
| Caucasian-vs-AfricanAmerican |
7.083800E-01 |
| Caucasian-vs-Asian |
5.859000E-01 |
| AfricanAmerican-vs-Asian |
6.329800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62725388719309E-12 |
| Normal-vs-Female |
1.502280E-02 |
| Male-vs-Female |
4.633700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.76449999999796E-05 |
| Normal-vs-Extreme_Weight |
1.2712053631958E-11 |
| Normal-vs-Obese |
2.17469999999054E-05 |
| Normal-vs-Extreme_Obese |
6.03979999347359E-09 |
| Normal_Weight-vs-Extreme_Weight |
2.132000E-01 |
| Normal_Weight-vs-Obese |
6.123800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.820100E-02 |
| Extreme_Weight-vs-Obese |
1.696450E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.240200E-01 |
| Obese-vs-Extreme_Obese |
5.039600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.062300E-03 |
| Normal-vs-Age(41-60Yrs) |
8.04300000000202E-05 |
| Normal-vs-Age(61-80Yrs) |
5.07371922253697E-14 |
| Normal-vs-Age(81-100Yrs) |
3.98730004569359E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.682000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.117900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.257600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.961700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.060010E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.934420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.15730005975945E-10 |
| Normal-VS-Type2 PRCC |
4.79829999955328E-07 |
| Normal-VS-KIRP CIMP |
5.782000E-02 |
| Normal-VS-Unclassified PRCC |
3.520300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.643650E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.678400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.054100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.587400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.563220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.462600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.10229999969758E-07 |
| Normal-vs-N1 |
8.801500E-04 |
| Normal-vs-N2 |
1.816220E-01 |
| N0-vs-N1 |
3.644800E-01 |
| N0-vs-N2 |
3.535200E-01 |
| N1-vs-N2 |
6.626000E-01 |
|
|
